scispace - formally typeset
T

Teona Serafimova

Researcher at University of Bristol

Publications -  13
Citations -  270

Teona Serafimova is an academic researcher from University of Bristol. The author has contributed to research in topics: Medicine & Chronic fatigue syndrome. The author has an hindex of 1, co-authored 6 publications receiving 12 citations.

Papers
More filters
Journal ArticleDOI

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

Obbina Abani, +7885 more
- 03 Mar 2022 - 
TL;DR: In patients hospitalised with COVID-19, baricitinib significantly reduced the risk of death but the size of benefit was somewhat smaller than that suggested by previous trials.
Journal ArticleDOI

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Alasdair Munro, +308 more
TL;DR: Safety and reactogenicity, and immunogenicity (anti-spike protein IgG titres by ELISA and cellular immune response by ELISpot) were primarily analysed in a modified intention-to-treat population comprising seronegative participants who had received a fourth-dose booster and had available endpoint data.
Journal ArticleDOI

Loneliness and mental health in children and adolescents with pre-existing mental health problems: A rapid systematic review.

TL;DR: In this paper, a rapid systematic search was conducted using MEDLINE, PsycINFO, and Web of Science to identify effective interventions that reduce the adverse impact of loneliness in children and young people with pre-existing mental health problems.
Journal ArticleDOI

Digital Behavior Change Interventions for Younger Children With Chronic Health Conditions: Systematic Review.

TL;DR: Using qualitative methods during digital intervention development and evaluation may lead to more meaningful, usable, feasible, and engaging interventions, especially for this underresearched younger population.